Dr. Mirko Corselli has over 15 years of academic and industry experience in the development of flow cytometry applications. He is passionate about driving the adoption of cutting-edge technologies through scientific communication. He received his Ph.D. in clinical and experimental hematology and oncology from the University of Genova, Italy. He spent two years at the University of Pittsburgh as a research scholar before continuing his research as a post-doctoral fellow at the University of California, Los Angeles. Most of his academic work has focused on the biology and therapeutic potential of human mesenchymal stromal cells (MSCs). During his tenure at BD Biosciences, he has led the development and dissemination of scientific content showcasing the application of high parameter flow cytometry and single-cell multiomic analysis in the field of immunology and immuno-oncology.

Bob Balderas has 40 years of leadership experience in both academia and the biotechnology industry and is recognized in the field as an immunology and flow cytometry domain expert. He has made significant contributions as a corporate scientist, site manager, and marketer. Bob has championed multiple successful key product launches during his tenure at Pharmingen and BD Biosciences, given more than 1500 scientific and technology presentations, and is recognized for his successes in creating critical collaborations with scientists to generate products that are relevant to BD’s customers. Bob influences the scientific community by serving on the editorial board of Clinical Proteomics, was involved with several business acquisitions, led two industrial/academic initiatives with CANVAC and the NCI, and contributes as a member on several key boards including the HCMD Council (Human Cell Differentiation Molecule), the UCSD Industrial Liaison Program, the Dean’s Council for the UCSD School of Biological Sciences, a Board Member of FOCIS, SAB Member of Inflamex in Paris, the Oz Single Cell Consortium, Human Single Cell Germany Consortium (Lifetime), a corporate member of the UCSD Jacobs School of Engineering, led the NIH/BDB Symphony CRADA and early development of BDB’s TLDP Recruiting Team.

Dr. Rodrigo Pestana has over 20 years of academic, diagnostic and industry experience. Rodrigo has a bachelor's degree in Pharmaceutical Sciences and Biochemistry, a master’s and a Ph.D. in Cellular and Molecular Biology - all from the Pontifical Catholic University of Rio Grande do Sul, in Brazil - and an MBA in Project Management. In the diagnostic field, Rodrigo has experience in hematology, hemostasis, clinical chemistry, and immunology and has been trained in the use of Flow Cytometry on hematological malignancies at the University of Salamanca, Spain. Rodrigo has authored or co-authored 17 published works in the fields of immunomodulation, vaccine research, immunosenescence, psychoneuroimmunology, and inflammation, with over 760 citations, and authored a book chapter in flow cytometry. As part of BD for 16 years, Rodrigo has given more than 500 scientific and technology talks and helped train and educate thousands of scientists, clinicians, and students from different countries.